| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malariometric surveys were conducted during July 1996 in native Dayak villages and predominantly Javanese transmigration settlements in Ketapang district of West Kalimantan, Indonesia. Malaria prevalence ranged from 0.9% to 2.7% in Dayak villages and from 1% to 20% in the transmigration settlements. Plasmodium falciparum accounted for 67% of the cases among Dayaks but P. vivax was dominant among transmigrants, accounting for more than 72% of the infections. Chloroquine sensitivity/resistance was assessed by 28-day in vivo testing of uncomplicated malaria infections and measurement of chloroquine blood levels in cases where parasitemias reappeared within the 28-day test period. Resistance was based on the appearance of asexual parasites against chloroquine plus desethylchloroquine levels exceeding the minimally effective whole blood concentrations proposed for sensitive parasite strains (P. vivax, 100 ng/ml; P. falciparum, 200 ng/ml). All parasitemias cleared initially within four days of beginning supervised chloroquine therapy (25 mg base/kg over a 48-hr period), but asexual parasites reappeared within 28 days in 27 of 52 P. vivax and three of 12 P. falciparum cases. Chloroquine blood levels at the time of recurrent parasitemias revealed resistance in 12 of the 27 P. vivax cases and in one of the three P. falciparum cases. Genotypes of nine of the 12 recurrent P. vivax isolates matched with their primary isolates and ruled out reinfection. These findings establish the presence of chloroquine-resistant P. vivax on the island of Borneo. The pattern of malaria and the high frequency of chloroquine resistance by P. vivax at the West Kalimantan location may relate to demographic, ecologic, agricultural, and socioeconomic changes associated with transmigration.
This article has been cited by other articles:
|
|
 |
|
  I. Sutanto, S. Suprijanto, Nurhayati, P. Manoempil, and J. K. Baird Resistance to Chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in Eastern Indonesia Am J Trop Med Hyg, August 1, 2009; 81(2): 338 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Baird Resistance to Therapies for Infection by Plasmodium vivax Clin. Microbiol. Rev., July 1, 2009; 22(3): 508 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Kim, S.-Y. Hwang, J. H. Shin, C.-S. Moon, D.-W. Kim, and W.-G. Kho Molecular Genetic Characterization of the Merozoite Surface Protein 1 Gene of Plasmodium vivax from Reemerging Korean Isolates Clin. Vaccine Immunol., May 1, 2009; 16(5): 733 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Barnadas, A. Ratsimbasoa, M. Tichit, C. Bouchier, M. Jahevitra, S. Picot, and D. Menard Plasmodium vivax Resistance to Chloroquine in Madagascar: Clinical Efficacy and Polymorphisms in pvmdr1 and pvcrt-o Genes Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4233 - 4240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Russell, F. Chalfein, B. Prasetyorini, E. Kenangalem, K. Piera, R. Suwanarusk, A. Brockman, P. Prayoga, P. Sugiarto, Q. Cheng, et al. Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1040 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey Vivax Malaria: Neglected and Not Benign Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 79 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Griffith, L. S. Lewis, S. Mali, and M. E. Parise Treatment of Malaria in the United States: A Systematic Review JAMA, May 23, 2007; 297(20): 2264 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Baird Chloroquine Resistance in Plasmodium vivax Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4075 - 4083. [Full Text] [PDF]
|
|
|
|
|
|
S. Brega, F. de Monbrison, C. Severini, R. Udomsangpetch, I. Sutanto, P. Ruckert, F. Peyron, and S. Picot Real-Time PCR for Dihydrofolate Reductase Gene Single-Nucleotide Polymorphisms in Plasmodium vivax Isolates Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2581 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. SUTANTO, S. SUPRIYANTO, P. RUCKERT, PURNOMO, J. D. MAGUIRE, and M. J. BANGS COMPARATIVE EFFICACY OF CHLOROQUINE AND SULFADOXINE-PYRIMETHAMINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA AND IMPACT ON GAMETOCYTE CARRIAGE RATES IN THE EAST NUSATENGGARA PROVINCE OF INDONESIA Am J Trop Med Hyg, May 1, 2004; 70(5): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Talisuna, P. Bloland, and U. D'Alessandro History, Dynamics, and Public Health Importance of Malaria Parasite Resistance Clin. Microbiol. Rev., January 1, 2004; 17(1): 235 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. ROSHANRAVAN, E. KARI, R. H. GILMAN, L. CABRERA, E. LEE, J. METCALFE, M. CALDERON, A. G. LESCANO, S. H. MONTENEGRO, C. CALAMPA, et al. ENDEMIC MALARIA IN THE PERUVIAN AMAZON REGION OF IQUITOS Am J Trop Med Hyg, July 1, 2003; 69(1): 45 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Worley, K. A. Worley, and P. L. Kumar Infectious Disease Challenges in Immigrants From Tropical Countries Pediatrics, July 1, 2000; 106(1): 3e - 3. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Soto and J. Berman Myocardial infarction associated with buprenorphine. Ann Intern Med, March 16, 1999; 130(6): 536 - 536. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
